Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting improvements in clinical outcomes.
Krupa D. Parekh, PharmD, MPH
Advertisement
Articles by Krupa D. Parekh, PharmD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Often Do Health Insurers Deny Doctor-Recommended Care?
2
Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM
3
Sudden Death in HFpEF Often Preceded by Clinical Decline
4
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
5